The ornithine decarboxylase inhibitor, difluoromethylornithine, inhibits casein kinase II activity, c-Myc expression and normal human keratinocyte proliferation.
Praskova
M
M
Department of Biochemistry, University of Medicine, Sofia, Bulgaria.
Kalenderova
S
S
Miteva
L
L
Poumay
Y
Y
Mitev
V
V
D047390:Casein Kinase II; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D000518:Eflornithine / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D015603:Keratinocytes / Q000166:cytology*; D065108:Ornithine Decarboxylase Inhibitors; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D016271:Proto-Oncogene Proteins c-myc / Q000037:antagonists & inhibitors*
D004791:Enzyme Inhibitors; D065108:Ornithine Decarboxylase Inhibitors; D016271:Proto-Oncogene Proteins c-myc; D047390:Casein Kinase II; D017346:Protein Serine-Threonine Kinases; D000518:Eflornithine